Sex‐specific effects of PNPLA3 I148M
Liver International · 2025
DOI: 10.1111/liv.16088 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Liver International, 2025. Verfasst von Alessandro Cherubini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine, Precision Medicine-Biological Resource Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, …. Hauptthemen laut MEDLINE: Sex Factors, Non-alcoholic Fatty Liver Disease, Genetic Variation, Phospholipases A2, Calcium-Independent. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Metabolic dysfunction–associated steatotic liver disease (MASLD, previously termed NAFLD, nonalcoholic fatty liver disease) is a complex multifactorial disease showing generally higher prevalence and severity in men than in women. With respect to women, men are also more prone to develop metabolic dysfunction–associated steatohepatitis, fibrosis and liver‐related complications. Several genetic, hormonal, environmental and lifestyle factors may contribute to sex differences in MASLD development, progression and outcomes. However, after menopause, the sex‐specific prevalence of MASLD shows an opposite trend between men and women, pointing to the relevance of oestrogen signalling in the sexual dimorphism of MASLD. The patatin‐like phospholipase domain‐containing protein 3 ( PNPLA3 ) gene, that encodes a triacylglycerol lipase that plays a crucial role in lipid metabolism, has emerged as a key player in the pathogenesis of MASLD, with the I148M variant being strongly associated with increased liver fat content and disease severity. Recent advances indicate that carrying the PNPLA3 I148M variant can be a risk factor for MASLD especially for women. To elucidate the molecular mechanisms underlying the sex‐specific role of PNPLA3 I148M in the development of MASLD, several in vitro, ex vivo and in vivo models have been developed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Transfusion Medicine, Precision Medicine-Biological Resource Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Medical Sciences, University of Turin, Turin, Italy.
- Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy.
ORCID-Profile: Alessandro Cherubini, Chiara Rosso, Sara Della Torre
Zitieren
APA
Cherubini, A., Rosso, C., & Della Torre, S. (2025). Sex‐specific effects of PNPLA3 I148M. Liver International. https://doi.org/10.1111/liv.16088
Vancouver
Cherubini A, Rosso C, Della Torre S. Sex‐specific effects of PNPLA3 I148M. Liver International. 2025. doi:10.1111/liv.16088
BibTeX
@article{Cherubini2025,
author = {Cherubini, Alessandro and Rosso, Chiara and Della Torre, Sara},
title = {Sex‐specific effects of PNPLA3 I148M},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.16088}
}
EUVIMED